BPC + TB Blend
Combined BPC 157 and TB500 blend used in recovery protocols to overlap angiogenic and cytoskeletal effects.
How it works
Pairs BPC 157's VEGFR2-eNOS-mediated angiogenesis with TB500's actin-sequestration-driven cell migration. The combination is hypothesised to be synergistic.
Reported benefits
- Convenience of dual mechanism in a single injection
- Reported faster perceived recovery in user surveys (anecdotal)
Dosage & administration
Typical research protocol: 250 mcg BPC + 250 mcg TB500 subcutaneously daily for 4 weeks.
Dosing information is summarised from published clinical and pre-clinical literature for research purposes only and does not constitute medical advice.
Safety & warnings
- See individual peptide entries
- No long-term combination data
For research use. Consult a licensed clinician before any human application. Not for use in pregnancy, lactation, or active malignancy without specialist supervision.
Available presentations
BPC 5mg + TB 5mg
BB10
Box of 10 · $351
Single vial · $702
BPC 10mg + TB 10mg
BB20
Box of 10 · $588
Single vial · $1,176
Related guides
BPC 157
A pentadecapeptide derived from human gastric juice with broad regenerative effects in pre-clinical models.
TB500 (Thymosin B4 Acetate)
A synthetic fragment of thymosin β-4 that promotes cell migration, angiogenesis, and tissue repair.
Klow (TB10 + BPC10 + GHK50 + KPV10)
Quad blend combining TB500, BPC 157, GHK-Cu, and KPV for systemic regeneration and anti-inflammatory effects.